Format

Send to

Choose Destination
J Hosp Infect. 2019 Nov 9. pii: S0195-6701(19)30444-X. doi: 10.1016/j.jhin.2019.10.009. [Epub ahead of print]

International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass.

Author information

1
Division of Infectious Diseases and Hospital Epidemiology, University Hospital and University of Zurich, Switzerland. Electronic address: barbara.hasse@usz.ch.
2
Clinical Microbiology, Mater Misericordiae University Hospital, Dublin, Ireland.
3
Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
4
Diagnostic Mycobacteriology Group, National and WHO Supranational Reference Center for Mycobacteria, Research Center, Borstel Germany.
5
Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
6
Departments of Medicine, Health Research Methods, Evidence and Impact, And Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
7
Department of Internal Medicine II, Division of Infectious Diseases, Medical Center, University of Freiburg, Freiburg I.Br, Germany.
8
Servei de Malalties Infeccioses(,) Hospital Universitari Vall D'Hebron(,) Universitat Autònoma de Barcelona, Barcelona, Spain.
9
Kaiser Permanente Infectious Diseases, Los Angeles Medical Center, Los Angeles, U.S.A.
10
Infectious and Tropical Diseases Department, San Bortolo Hospital, Vincenca, Italy.
11
Institute of Anesthesiology, University Hospital Zurich, Switzerland.
12
Department of Anaesthesiology, Kaiser Permanente, Los Angeles Medical Center, Los Angeles, U.S.A.
13
Infectious and Transplant Medicine, University of Campania 'L. Vanvitelli', Monaldi Hospital, Naples, Italy.
14
Division of Infectious Diseases, Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
15
Monash Infectious Diseases, Monash Health, Australia.
16
Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Denmark.
17
Department of Infectious Diseases, Cleveland Clinic, Ohio, U.S.A.
18
Acute Communicable Disease Control, Los Angeles Department of Public Health, Los Angeles, USA.
19
Division of Infectious Diseases and Hospital Epidemiology, University Hospital and University of Zurich, Switzerland.
20
Molecular and Experimental Mycobacteriology Group, Research Center, Borstel Germany; German Center for Infection Research (DZIF), Partner Site Hamburg - Lübeck - Borstel - Riems, Borstel, Germany.
21
Molecular and Experimental Mycobacteriology Group, Research Center, Borstel Germany.
22
Division of Mycobacterial and Respiratory Infections, National Jewish Health, Denver Colorado, U.S.A.
23
Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Australia.
24
Penn State Health, Milton S. Hershey Medical Center, Hershey, Pennsylvania, U.S.A.
25
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, USA.
26
Healthcare-associated Infections, European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
27
National Infection Service, Public Health England.
28
National Infection Service, Public Health England; Guy's and St Thomas' NHS Foundation Trust, Imperial College London, London, England.
29
Centre for Cardiovascular Surgery and Transplantation, Brno, and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
30
Ophthalmology Unit, University of Zurich, Switzerland.
31
National Center for Mycobacteria, Zurich, Switzerland; Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
32
National Center for Mycobacteria, Zurich, Switzerland.
33
Department of Infection and Tropical Medicine, University Hospitals Birmingham, Birmingham, UK.
34
Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
35
Clinic for Cardiovascular Surgery, University Hospital and University of Zurich, Switzerland.
36
Division of Infectious Diseases, University of Iowa, Carver College of Medicine, Iowa, U.S.A.
37
Department of Microbiology, The University of Texas Health Science Center at Tyler, Tyler, Texas, U.S.A.
38
Division of Infectious Diseases, Departments of Medicine and Cardiovascular Medicine, Mayo Clinic, College of Medicine and Science, Rochester, Minnesota, U.S.A.
39
Infectious Diseases Service at the Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.
40
Department of Infectious Diseases and Tropical Medicine, University Medical Center of Nancy, Vandoeuvre Cedex, France. Electronic address: bruno@hoen.pro.

Abstract

Mycobacterial infection-related morbidity and mortality in patients following cardiopulmonary bypass surgery is high and and there is a growing need for a consensus-based expert opinion to provide international guidance for diagnosing, preventing and treating in these patients. In this document the International Society for Cardiovascular Infectious Diseases (ISCVID) covers aspects of prevention (field of hospital epidemiology), clinical management (infectious disease specialists, cardiac surgeons, ophthalmologists, others), laboratory diagnostics (microbiologists, molecular diagnostics), device management (perfusionists, cardiac surgeons) and public health aspects.

KEYWORDS:

ISCVID; Mycobacterium chimaera; cardiopulmonary bypass; disseminated; guidelines; heater-cooler device; infection; mycobacterial; outbreaks

PMID:
31715282
DOI:
10.1016/j.jhin.2019.10.009
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center